MedTrace Logo

Gabapentin as Adjunctive Treatment for Postoperative Pain Control

NCT02490345 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-08-23

No results posted yet for this study

Summary

The specific aims of this research study are to use 600 mg gabapentin as an adjunctive treatment for acute postoperative pain control in order to reduce postoperative opiate consumption and improve postoperative pain control.

Conditions

  • Drug Usage

Interventions

DRUG

gabapentin

gabapentin usage as adjunctive treatment for pain control

DRUG

Placebo

Identical placebo

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • David Haas, MD, MS · Indiana School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-06-29
Completion
2017-06-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490345 on ClinicalTrials.gov